SPECIAL
ISSUE
India
Pharma Inc. A retrospective and prospective view
- - GRK Murty
Introducing,
sustaining and assessing a new patent regime is of course a political
process, but it inevitably alters present manufacturing techniques or
threatens to alter existing relationships. The resulting question is how
to navigate the transition. Entrepreneurs have to obviously invent new
methods of doing business. They have to rebuild their competencies by
fostering collaboration with whomsoever required, and that is what this
article analyzes.
© 2005 IUP. All Rights Reserved
SPECIAL
ISSUE
New
patent regime - Pharma patents
- - AV Narsimha Rao
The
Indian pharma sector has succeeded to a great extent in the recent past
due to practices like reverse engineering. But now the product patent
regime brings along the challenge of thriving on "discovery based", which
involves huge investments and time. The article throws light on the patent
regime and its impact on the Indian pharma sector.
© 2005 IUP. All Rights Reserved
SPECIAL
ISSUE
Role
of CRM in pharma marketing
- - Shanthi Venkatesh
CRM
has a different perspective in the pharma sector. The relevance of CRM
in the pharma sector is rooted in marketing efforts, which enhances relationship
with customers, and builds a network of loyal customers. This article
throws light on the present situation of the pharma markets, the essentials
of pharma marketing and relevance of CRM in building a relationship through
pharma marketing.
© 2005 IUP. All Rights Reserved.
SPECIAL
ISSUE
Ranbaxy-Company
profile
- - Spokesperson
Ranbaxy
Laboratories Limited, India's largest pharmaceutical Company, manufactures
and markets brand and generic pharmaceuticals and active pharmaceutical
ingredients. Ranbaxy's continued focus on R&D has resulted in several
approvals in developed markets and significant progress in New Drug Discovery
Research. Ranbaxy's foray into Novel Drug Delivery Systems has led to
proprietary "platform technologies" resulting in a number of products
underdevelopment. The Company is selling its products in over 100 countries
and has an expanding international portfolio of affiliates, joint ventures
and alliances, ground operations in 44 countries and manufacturing operations
in 7 countries.
© 2005 Ranbaxy Laboratories Limited. All Rights Reserved.
SPECIAL
ISSUE
Pharma
industry-No longer old tonic in new bottle
- - Anitha Dilipan
The
ordinance passed in the Indian Patents Act to make India WTO compliant,
marked January 1, 2005 as the doomsday for many pharma companies, who
have been surviving in the industry by manufacturing generic drugs. So
far, Indians have been used to purchasing drugs at cheap prices and having
a variety of drugs to choose from for the same malady. In this scenario,
the article analyzes how new drugs, which evolve out of pure research
in India will be accepted in the market.
© 2005 IUP. All Rights Reserved
SPECIAL
ISSUE
Innovation
in Indian pharma: The key to success
- - Krishna Kumar
This
article talks about innovation in the national pharma sector, growth potential,
strategic creation of product lines, effect of patent changes, innovative
practice, segmental focus, important manufacturers and the national laboratories.
© 2005 IUP. All Rights Reserved
SPECIAL
ISSUE
Ranbaxy
Laboratories
- - AV Vedpuriswar
Ranbaxy
Laboratories, one of India's leading pharmaceutical companies has been
spearheading the industry with its leading innovations and far reaching
business horizons. Ranbaxy Laboratories also holds the credit of being
the first Indian multinational company. This article throws light on the
reasons behind Ranbaxy's phenomenal success.
© 2005 IUP. All Rights Reserved
SPECIAL
ISSUE
Biocon-Kiran
Mazumdar Shaw's entrepreneurial dream
- - Vivek Gupta
Biocon
India (Biocon), the number one biotech company in Asia in terms of revenue
and market capitalization, was founded in the backyard of a suburban house
in Bangalore in 1978 as a small operation of enzyme extraction. This article
describes how Kiran Mazumdar Shaw recognized the future potential of biotechnology
when not many people in India knew about it. Overall, this article focuses
on `opportunity recognition and exploitation processes,' and `managing
start-up and growth,' while highlighting the role and importance of women
entrepreneurs and the problems they face when doing business in India.
© 2005 ICMR. All Rights Reserved
SPECIAL
ISSUE
Merck
in 2004-Managing product development
- - AV Vedpuriswar
Merck,
is a major player in the global pharmaceutical industry. At present, Merck
is going through turbulent times due to lack of discoveries, exhausting
patented-products and dwindling share prices. This article focuses on
the crises Merck is facing and the tentative strategies lying before Merck
to get back on track.
© 2005 IUP. All Rights Reserved
|